메뉴 건너뛰기




Volumn 30, Issue 2, 2007, Pages 192-193

Cure of Candida glabrata native tricuspid valve endocarditis by continuous infusion of conventional amphotericin B in a patient with nephrotic syndrome

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ENALAPRIL; FLUCONAZOLE; FUROSEMIDE; LEVOFLOXACIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

EID: 34250791615     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.04.007     Document Type: Letter
Times cited : (8)

References (7)
  • 2
    • 0035282477 scopus 로고    scopus 로고
    • Mortality and costs of acute renal failure associated with amphotericin B therapy
    • Bates D.W., Su L., Yu D.T., et al. Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis 32 (2001) 686-693
    • (2001) Clin Infect Dis , vol.32 , pp. 686-693
    • Bates, D.W.1    Su, L.2    Yu, D.T.3
  • 3
    • 0035835901 scopus 로고    scopus 로고
    • Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 h: randomised controlled trial
    • Eriksson U., Seifert B., and Schaffner A. Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 h: randomised controlled trial. BMJ 322 (2001) 579-582
    • (2001) BMJ , vol.322 , pp. 579-582
    • Eriksson, U.1    Seifert, B.2    Schaffner, A.3
  • 4
    • 6344220071 scopus 로고    scopus 로고
    • Continuous and 4 h infusion of amphotericin B: a comparative study involving high-risk haematology patients
    • Peleg A.Y., and Woods M.L. Continuous and 4 h infusion of amphotericin B: a comparative study involving high-risk haematology patients. J Antimicrob Chemother 54 (2004) 803-808
    • (2004) J Antimicrob Chemother , vol.54 , pp. 803-808
    • Peleg, A.Y.1    Woods, M.L.2
  • 5
    • 0037445546 scopus 로고    scopus 로고
    • Continuous infusion of escalated dose of amphotericin B deoxycholate: an open-label observational study
    • Imhof A., Walter R.B., and Schaffner A. Continuous infusion of escalated dose of amphotericin B deoxycholate: an open-label observational study. Clin Infect Dis 36 (2003) 943-951
    • (2003) Clin Infect Dis , vol.36 , pp. 943-951
    • Imhof, A.1    Walter, R.B.2    Schaffner, A.3
  • 6
    • 2442704002 scopus 로고    scopus 로고
    • Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy
    • Groll A.H., and Kolve H. Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy. Eur J Clin Microbiol Infect Dis 23 (2004) 256-270
    • (2004) Eur J Clin Microbiol Infect Dis , vol.23 , pp. 256-270
    • Groll, A.H.1    Kolve, H.2
  • 7
    • 0032459632 scopus 로고    scopus 로고
    • An EORTC international multicentre randomised trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis
    • Ellis M., Spence D., de Pauw B., et al. An EORTC international multicentre randomised trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis. Clin Infect Dis 27 (1998) 1406-1412
    • (1998) Clin Infect Dis , vol.27 , pp. 1406-1412
    • Ellis, M.1    Spence, D.2    de Pauw, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.